Targeting Multiple Tumors And Viral Infected Cells Using T-Cells Engineered To Express A Ncr-Based Chimeric Antigen Receptor.

Research output: Contribution to conferencePaperpeer-review

Original languageAmerican English
StatePublished - 2018
EventInternational Conference for Lymphocyte Engineering - , Spain
Duration: 12 Sep 201816 Sep 2018

Conference

ConferenceInternational Conference for Lymphocyte Engineering
Country/TerritorySpain
Period12/09/1816/09/18

Cite this